[1]Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8):1941-1953.
[2]Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[3]Xu WW, Huang ZH, Liao L, et al. Direct targeting of CREB1 with imperatorin inhibits TGFβ2ERK signaling to suppress esophageal cancer metastasis[J]. Adv Sci (Weinh), 2020, 7(16): 2000925.
[4]李冉冉,袁冰,张颖,等. 乳腺癌细胞分泌的血管内皮生长因子诱导肺预转移小生境的形成[J]. 中华肿瘤杂志, 2016, 38(1): 17-22.
[5]Kahn BM, Lucas A, Alur R, et al. The vascular landscape of human cancer[J]. J Clin Invest, 2021, 131(2):e136655.
[6]凌薇,宋玉洁,汪慧,等. 刚地弓形虫RH株速殖子外泌体的分离与鉴定[J]. 江苏大学学报(医学版), 2020, 30(3): 239-242.
[7]Guo S, Chen J, Chen F, et al. Exosomes derived from Fusobacterium nucleatuminfected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR1246/92b3p/27a3p and CXCL16[J]. Gut, 2020. DOI:10.1136/gutjnl2020321187.
[8]Sun W, Ren Y, Lu Z, et al. The potential roles of exosomes in pancreatic cancer initiation and metastasis[J]. Mol Cancer, 2020, 19(1): 135.
[9]周新茹,金倩,张蕾蕾,等. 人脐带间充质干细胞来源外泌体促进小胶质细胞向M2极化[J]. 江苏大学学报(医学版), 2020, 30(4): 277-281.
[10]赵佳伟,施敏,郑金旭. 间充质干细胞外泌体调控氧化应激减轻D氨基半乳糖/脂多糖诱导的急性肝损伤[J]. 江苏大学学报(医学版), 2020, 30(4): 287-292.
[11]胡玉燕,尹磊,张晨笑,等. 脐带间充质干细胞外泌体对大鼠肾间质纤维化的抑制作用[J]. 江苏大学学报(医学版), 2020, 30(4): 282-286.
[12]唐雨婷,乔佳琦,许文荣,等. 外泌体在糖尿病及其并发症中的作用研究进展[J]. 江苏大学学报(医学版), 2020, 30(4): 298-301.
[13]Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 200014 (CONCORD3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 populationbased registries in 71 countries[J]. Lancet, 2018, 391(10125): 1023-1075.
[14]Fane ME, Ecker BL, Kaur A, et al. sFRP2 Supersedes VEGF as an agerelated driver of angiogenesis in melanoma, affecting response to antiVEGF therapy in older patients[J]. Clin Cancer Res, 2020, 26(21): 5709-5719.
[15]毛佳慧,梁照锋,田伊卿,等. 不同状态p53小鼠骨髓间质干细胞分泌外泌体的差异[J]. 江苏大学学报(医学版), 2017, 27(2): 103-106.
[16]Yang Y, Guo Z, Chen W, et al. M2 macrophagederived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2[J]. Mol Ther, 2020, 29(3):1226-1238.
[17]Di Modica M, Regondi V, Sandri M, et al. Breast cancersecreted miR939 downregulates VEcadherin and destroys the barrier function of endothelial monolayers[J]. Cancer Lett, 2017, 384: 94-100.
[18]Zeng Z, Li Y, Pan Y, et al. Cancerderived exosomal miR253p promotes premetastatic niche formation by inducing vascular permeability and angiogenesis[J]. Nat Commun, 2018, 9(1): 5395.
[19]Hsu Y, Hung J, Chang W, et al. Hypoxic lung cancersecreted exosomal miR23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO1[J]. Oncogene, 2017, 36(34): 4929-4942.
[20]Frawley T, Piskareva O. Extracellular vesicle dissemination of epidermal growth factor receptor and ligands and its role in cancer progression[J]. Cancers (Basel), 2020, 12(11):3200.
[21]Xie J, Wei J, Lv L, et al. Angiopoietin2 induces angiogenesis via exosomes in human hepatocellular carcinoma[J]. Cell Commun Signal, 2020, 18(1):46.
[22]王鸣,宋廉,张礼荣,等. 低氧诱导胰腺癌细胞通过外泌体途径分泌高迁移率族蛋白1[J]. 江苏大学学报(医学版), 2019, 29(2): 98-102.
[23]倪修凡,张尤历,徐岷. 外泌体源性长链非编码RNA在消化系统肿瘤中的研究进展[J]. 江苏大学学报(医学版), 2020, 30(4): 293-297.
[24]Zhang C, Luo Y, Cao J, et al. Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR206 to upregulate NETO2 and FOXP1 expression[J]. Cancer Med, 2020, 9(22): 8600-8611.
[25]王娟娟,贾浩源,张斌,等. 人脐带间质干细胞来源的外泌体对顺铂抗肿瘤疗效的影响[J]. 江苏大学学报(医学版), 2017, 27(3): 190-193.
[26]Zeng Y, Yao X, Liu X, et al. Antiangiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis[J]. J Extracell Vesicles, 2019, 8(1): 1629865.
[27]Im E, Lee C, Moon P, et al. Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A[J]. Nat Commun, 2019, 10(1):1387.
[28]Liao Y, Wang C, Yang Z, et al. Dysregulated Sp1/miR130b3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma[J]. Theranostics, 2020, 10(12): 5209-5224.
[29]Hegde PS, Wallin JJ, Mancao C. Predictive markers of antiVEGF and emerging role of angiogenesis inhibitors as immunotherapeutics[J]. Semin Cancer Biol, 2018, 52(Pt 2): 117-124.
[30]Ladeira K, Macedo F, LongattoFilho A, et al. Angiogenic factors: role in esophageal cancer, a brief review[J].Esophagus, 2018, 15(2): 53-58.
|